Tender detail
Antineoplastic medicines 2026
Summary
Fakultní nemocnice Plzeň is procuring a four-year supply of medicines for the treatment of malignant diseases, comprising an estimated 12,680 doses across four lots. The lots cover medicines containing pertuzumab and trastuzumab, rituximab, entrectinib, and polatuzumab vedotin, for use in the hospital’s healthcare facilities.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.